Oncotelic Presenting at BiotechGate Digital Partnering

AGOURA HILLS, Calif., Jan. 19, 2022 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (Oncotelic or the Company) (OTCQB:OTLC), a leading developer of TGF- therapeutics for oncology and virology, today announced that Dr. Vuong Trieu, Oncotelic Chairman and CEO, will be presenting the Company immunotherapy pipeline at BiotechGate Digital Partnering Feb 7 - 11, 2022.